Generation of percentile curves for strength and functional abilities for boys with Duchenne muscular dystrophy

Mariana Angélica De Souza Leon1, Daiane Leite Da Roza2, Gabriela Barroso De Queiroz Davoli1

  • 1Department of Health Science, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Muscle & Nerve
|June 15, 2023
PubMed

Insights

New percentile curves for Duchenne muscular dystrophy (DMD) track functional abilities, muscle strength, and range of motion. These tools help monitor disease progression in DMD patients from age 4 to 18.

Area of Science:

  • Neurology
  • Pediatrics
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) presents with heterogeneous clinical manifestations.
  • Understanding the trajectory of functional decline is crucial for patient management.

Purpose of the Study:

  • To develop percentile curves for Duchenne muscular dystrophy (DMD) using a comprehensive battery of functional measures.
  • To establish reference standards for motor function, muscle strength, and range of motion in DMD patients across different ages.

Main Methods:

  • Retrospective analysis of 329 patient records (ages 4-18) with DMD.
  • Utilized Motor Function Measure (MFM) scale, isometric strength (IS), dorsiflexion range of motion (ROM), 10-meter walk test (10 MWT), and 6-minute walk test (6 MWT).
  • Constructed percentile curves (25th, 50th, 75th) using generalized additive models.

Main Results:

  • MFM percentiles demonstrated a consistent decline across all dimensions with age.
  • Knee extensor strength and dorsiflexion ROM were significantly affected early (from age 4 and 8, respectively).
  • 10 MWT performance time increased with age, while 6 MWT distance remained stable until age 8 before declining.

Conclusions:

  • Generated age-specific percentile curves for key functional measures in DMD.
  • These curves provide valuable tools for healthcare professionals and caregivers to monitor DMD disease progression.
  • Facilitates standardized assessment and tracking of functional abilities in Duchenne muscular dystrophy patients.
Abstract